Authors:
RUST S
WALTER M
FUNKE H
VONECKARDSTEIN A
CULLEN P
KROES HY
HORDIJK R
GEISEL J
KASTELEIN J
MOLHUIZEN HOF
SCHREINER M
MISCHKE A
HASHMANN HW
ASSMANN G
Citation: S. Rust et al., ASSIGNMENT OF TANGIER-DISEASE TO CHROMOSOME 9Q31 BY A GRAPHICAL LINKAGE EXCLUSION STRATEGY, Nature genetics, 20(1), 1998, pp. 96-98
Authors:
FOUBERT L
BRUIN T
DEGENNES JL
EHRENBORG E
FURIOLI J
KASTELEIN J
BENLIAN P
HAYDEN M
Citation: L. Foubert et al., A SINGLE SER259ARG MUTATION IN THE GENE FOR LIPOPROTEIN-LIPASE CAUSESCHYLOMICRONEMIA IN MOROCCAN OF BERBER ANCESTRY, Human mutation, 10(3), 1997, pp. 179-185
Authors:
KUIVENHOVEN JA
PRITCHARD H
HILL J
FROHLICH J
ASSMANN G
KASTELEIN J
Citation: Ja. Kuivenhoven et al., THE MOLECULAR PATHOLOGY OF LECITHIN - CHOLESTEROL ACYLTRANSFERASE (LCAT) DEFICIENCY SYNDROMES, Journal of lipid research, 38(2), 1997, pp. 191-205
Authors:
STROES E
KASTELEIN J
COSENTINO F
ERKELENS W
WEVER R
KOOMANS H
LUSCHER T
RABELINK T
Citation: E. Stroes et al., TETRAHYDROBIOPTERIN RESTORES ENDOTHELIAL FUNCTION IN HYPERCHOLESTEROLEMIA, The Journal of clinical investigation, 99(1), 1997, pp. 41-46
Authors:
OSE L
SCOTT R
BRUSCO O
UGARTE AC
DESCAMPS O
HELLER F
PAQUOT N
SCHEEN A
BERTOLAMI MC
FORTI N
RICHTER W
SELMAIER A
ZIEGLASCH HJ
KLOER H
BADE R
WANNER C
KOESTER W
KRAEMERGUTH A
BILIANOU H
LEFKOS N
EFTHIMIADIS A
KASTELEIN J
VANDAM M
VANDEWIEL A
LINTOTT C
SUNDT E
ISTAD H
LOENNECHEN CW
UTNE E
HOLE T
SKARE S
URHEIM S
CAMPODINCO S
MORALES R
IZA A
ALVAREZ L
SY R
YEBES R
LEE CY
TAN A
QUEK S
VERMAK WJH
VORSTER HH
RAAL FJ
KELLER U
NOSEDA G
BONETTI T
CRAWFORD GM
BLOOMFIELD P
SUTHERLAND K
RYLANCE PB
BROOM J
BAKSI AK
LANT AF
HUGHES EA
Citation: L. Ose et al., DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Clinical drug investigation, 10(3), 1995, pp. 127-138
Authors:
REYMER PWA
GAGNE E
GROENEMEYER BE
ZHANG HF
FORSYTH I
JANSEN H
SEIDELL JC
KROMHOUT D
LIE KE
KASTELEIN J
HAYDEN MR
Citation: Pwa. Reymer et al., A LIPOPROTEIN-LIPASE MUTATION (ASN291SER) IS ASSOCIATED WITH REDUCED HDL CHOLESTEROL LEVELS IN PREMATURE ATHEROSCLEROSIS, Nature genetics, 10(1), 1995, pp. 28-34
Authors:
MA YH
LIU MS
CHITAYAT D
BRUIN T
BEISIEGEL U
BENLIAN P
FOUBERT L
DEGENNES JL
FUNKE H
FORSYTHE I
BLAICHMAN S
PAPANIKOLAOU M
ERKELENS DW
KASTELEIN J
BRUNZELL JD
HAYDEN MR
Citation: Yh. Ma et al., RECURRENT MISSENSE MUTATIONS AT THE FIRST AND 2ND BASE OF CODON ARG(243) IN HUMAN LIPOPROTEIN-LIPASE IN PATIENTS OF DIFFERENT ANCESTRIES, Human mutation, 3(1), 1994, pp. 52-58
Authors:
DAUBRESSE JC
DEBACKER G
DUCOBU J
HARVENGT C
DEGENNES JL
DOUSTEBLAZY P
FARNIER M
ANDERS G
DAMMANN HG
NEUMANN E
SCHWARZE B
SEIFART C
KASTELEIN J
STALENHOEF A
KEIDAR S
CAPURSO A
DECESARIS R
DESCOVICH G
FELLIN R
FERUGLIO F
MALINI P
TRIMARCO B
SCOTT R
MARAIS A
KELLER U
MOCCETTI T
BLOOMFIELD P
CRAMB R
HUGHES E
SEED M
WRAY R
STEIN E
FRUCHART J
SWEANY A
SHAPIRO D
TATE A
Citation: Jc. Daubresse et al., COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN FOR HYPERCHOLESTEROLEMIA, The American journal of cardiology, 71(16), 1993, pp. 1408-1414